-+ 0.00%
-+ 0.00%
-+ 0.00%

Cellectar Biosciences Plunges on Pursuit of Strategic Options for Cancer Drug Candidate, 60% Workforce Cut

Dow Jones·12/11/2024 18:29:00

Please log in to view news